EUCTR2017-001206-16-DK进行中（未招募）1 期
Treatment of primary minimal change nephropathy.A randomized, open-labeled, non-inferiotiry study on prednisolone and vitamin D
Aarhus University hospital0 个研究点目标入组 96 人开始时间: 2017年5月5日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 96
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Biopsi proven minimal change nephropathy
- •If earlyer minimal change: No relaps in 5 years, and earlier only treated with prednisolone
- •Nephrotic syndrome
- •Age more than 18 years
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 70
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 26
排除标准
- •Cancer exceps from basal celle carcinoma
- •Lymphoproliferative disease
- •eGFR < 30 ml/min/1,73m2 (CKD-EPI)
- •No danish language
- •No ability to give informed prove
研究者
相似试验
已完成
3 期
Initial treatment of idiopathic nephrotic syndrome in children with mycophenolate mofetil vs. prednisone: A randomized, controlled, multicenter studyN04.9DRKS00006547niversitätsklinikum Heidelberg272
进行中（未招募）
1 期
Initial treatment of nephrotic syndrome in childreEUCTR2014-001991-76-DERuprecht-Karls-University Heidelberg, Medical Faculty represented by Universitätsklinikum Heidelberg and its Commercial340
已完成
4 期
Active Vitamin D and Reduced Dose Prednisolone for Treatment in Minimal Change NephropathyMinimal Change DiseaseNephrotic SyndromeNCT03210688University of Aarhus71
招募中
不适用
Reducing renal function deterioration by means of increasing medication adherence, improving immunosuppressive drug exposure and supporting a healthy lifestyle - an implementation studyRenal transplantationImmunosuppressantsMedication adherencee-HealthPatient participationNL-OMON20914eiden University Medical Center, Leiden, The Netherlands100
已完成
不适用
Reducing renal function deterioration by means of increasing medication adherence, improving immunosuppressive drug exposure and supporting a healthy lifestyle - an implementation study.NL-OMON50600eids Universitair Medisch Centrum100